Clinical Trials on Imatinib
Total 27 results
-
Novartis PharmaceuticalsCompletedCML | Nilotinib | Imatinib Resistant | Imatinib IntolerantKorea, Republic of
-
Novartis PharmaceuticalsCompletedImatinib | CMLKorea, Republic of
-
First Affiliated Hospital Bengbu Medical CollegeUnknownMalignant Ascites | ApatinibChina
-
Novartis PharmaceuticalsCompletedUrogenital Neoplasms | Genital Neoplasms, Male | Prostatic Diseases | Antineoplastic Agents | Imatinib | Prostatic Neoplasm | Genital Diseases, Male | Neoplasms, AbdominalGermany
-
Seoul St. Mary's HospitalMinistry of Health & Welfare, KoreaUnknownChronic Myeloid Leukemia | Imatinib | Complete Molecular ResponseKorea, Republic of
-
Shenzhen People's HospitalUnknownNSCLC | Apatinib | EGFR-TKIChina
-
National Cancer Institute (NCI)CompletedSclerotic Graft Versus Host Disease | Imatinib MesylateUnited States
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingIntrahepatic Cholangiocarcinoma | Apatinib | PD-1 Antibody | Transarterial ChemoembolizationChina
-
First Affiliated Hospital Bengbu Medical CollegeUnknownGastric Cancer | Apatinib | BiomarkerChina
-
Shenzhen Second People's HospitalHainan General Hospital; Sanya Central Hospital; First Affiliated Hospital of... and other collaboratorsRecruitingChronic Myeloid Leukemia, Chronic Phase | Flumatinib | ImatinibChina
-
Nanchong Central HospitalWithdrawnColorectal Cancer | Surgery | Outcome, Fatal | Adjuvant Chemotherapy | ApatinibChina
-
National University Hospital, SingaporeUnknownAsian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With ImatinibSingapore
-
Huashan HospitalCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownMetastasis | Thyroid | ApatinibChina
-
Fudan UniversityNot yet recruitingNeoplasms | Stomach Neoplasms | Gastrointestinal Neoplasms | Digestive System Neoplasms | Stomach Diseases | Molecular Mechanisms of Pharmacological Action | Capecitabine | Apatinib
-
Henan Cancer HospitalUnknownAdvanced Cancer | Mucosal Melanoma | Apatinib | SHR-1210China
-
Hangzhou Cancer HospitalUnknownEsophageal Cancer | Apatinib | Metastatic Esophageal CancerChina
-
Peking University Cancer Hospital & InstituteRecruitingMelanoma | Temozolomide | Apatinib | Camrelizumab | Acral Melanoma | Neoadjuvant | Pathological ResponseChina
-
Chang-Ming Huang, Prof.Active, not recruitingNeoadjuvant Therapy | SOX | Locally Advanced Gastric Cancer | Apatinib CombinedChina
-
Sun Yat-sen UniversityRecruitingNeoadjuvant Therapy | Apatinib | Carilizumab | Recurrent High-Grade GliomaChina
-
Novartis PharmaceuticalsTerminatedCML | Philadelphia Chromosome Positive (Ph+) | Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough LevelsUnited States
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownApatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCLung Cancer | Non Small Cell Lung Cancer | Apatinib | Combination ChemotherapyChina
-
Ruijin HospitalActive, not recruitingPulmonary Metastases | Osteosarcoma | ApatinibChina
-
Junling LiUnknownApatinib in Maintenance TreatmentChina
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 InhibitorChina
-
The First Affiliated Hospital with Nanjing Medical...UnknownSystematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast CancerChina
-
Shanghai Chest HospitalUnknownRecurrence | Metastasis | Esophageal Squamous Cell Carcinoma | ApatinibChina